Chromosomal translocation products engender new intracellular therapeutic technologies.

Chromosomal translocations occur in leukemias, lymphomas, sarcomas and some epithelial tumors and some generate unique fusion proteins. These translocation products may provide tumor-specific targets for the development of new therapeutic strategies tailored to a malignant cell.

書誌詳細
主要な著者: Rabbitts, T, Stocks, MR
フォーマット: Journal article
言語:English
出版事項: 2003

類似資料